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S U M M A R Y
Background: The association between Helicobacter pylori gene diversity and gastric cancer has been
poorly reported, although it is one of the important ways to explain the gastric pathogenesis. The aim of
this study was to investigate the frequency of cagE and virB11 genes in H. pylori isolated from patients
with gastric cancer and to analyze the histology proﬁles.
Materials and methods: The presence of H. pylori and subtypes (cagE and virB11) was detected by PCR
from the genomic DNA of 101 patients who had been diagnosed with gastric cancer. The cases were
grouped according to the presence/absence of the genes studied and were analyzed in relation to
histopathological parameters.
Results: H. pylori infection was detected in 94 out of 101 (93.1%) gastric carcinomas. The cases were
categorized into the following groups: cagE+/virB11+, cagE+/virB11, cagE/virB11+, and cagE/
virB11. Frequencies were: 50% (47/94) cagE+/virB11+, 3.2% (3/94) cagE+/virB11, 10.6% (10/94) cagE/
virB11+, and 36.2% (34/94) cagE/virB11. Tumors in the gastric antrum were predominant. An
exception was the cagE/virB11 group, in which tumors had a tendency to be located in the gastric
cardia; the majority of the cardia tumors (56% (14/25)) were in this group. Intestinal histology type was
the most frequent, but the cagE+/virB11 group only had diffuse tumors. H. pylori cagE+/virB11+
occurred most frequently (except at stage III), and was present at all gastric cancer stages.
Conclusions: This study is the ﬁrst to include a relevant number of gastric cancer cases with H. pylori
infection, reporting the frequency and relationship of cagE and virB11 genes and the genesis of this
tumor. The presence of these cag pathogenicity island genes shows that they are important factors for
the pathogenesis and malignancy of gastric cancer related to H. pylori.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Helicobacter pylori is a Gram-negative bacterium that has been
associated with diverse pathologies of varying severity, such as
chronic gastritis, peptic ulcer, mucosa-associated lymphoid tissue
(MALT) lymphoma, and gastric carcinoma.1 Although most
infected persons remain asymptomatic, 15–20% of H. pylori-
positive individuals will develop the associated diseases. This
could be dependent on environmental factors, host genetic factors
or speciﬁc properties of the microorganism.1
There is some evidence that the presence of certain virulence
factors is important in the organism’s ability to cause different
diseases. Several bacterial virulence factors have been suggested,
including the vacuolating cytotoxin (VacA) and the cytotoxin-* Corresponding author. Tel.: +55 85 8805 0432; fax: +55 85 3267 3840.
E-mail address: valeskacb@yahoo.com.br (V.P. Lima).
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doi:10.1016/j.ijid.2009.09.006associated gene A antigen (CagA). However, data supporting these
ﬁndings are insufﬁcient to explain the variety and severity of the
relateddiseases.One important virulence factor ofH. pylori is the cag
pathogenicity island (cag-PAI). This contains 31 genes, including the
cagA gene, but also codes for six proteins of a putative type IV
secretion system, specialized in the transfer of a variety of protein
complexes across the bacterialmembrane to the extracellular space
or into the host cells.2,3 One of the cag-PAI genes is cagE, located in
the righthalfof the cag-PAI.1,4–6Sozzi et al.6 and Ikenoueet al.7 have
suggested that this gene is a more accurate marker of an intact cag-
PAI than other cag genes. Another gene that codiﬁes proteins of a
type IV secretion system is virB11. This gene is located in the left half
of the cag-PAI. The VirB11 protein has a ring-shaped structure
composed of six monomeric units. It is important for the
transportation of protein complexes and exhibits ATPase activity.8,9
Several studies have described an association betweenH. pylori cagE
and gastritis, duodenal ulcer, and peptic ulcer disease.10–12 Only a
few studies have described an association with gastric cancer, but
the number of cases included has been small and therefore the testses. Published by Elsevier Ltd. All rights reserved.
Fig. 1. Distribution of cases by tumor stage (IA, IB, II, III and IV) in the four deﬁned
groups: cagE+/virB11, cagE/virB11+, cagE+/virB11 and cagE/virB11.
Table 1
Correlation between gastric sites and the four determinate groups
Cardia Non-cardia p-Value
cagE+/virB11 0 (0%) 3 (4.3%) 0.422
cagE/virB11+ 3 (12%) 7 (10.2%) 0.471
cagE+/virB11+ 8 (32%) 39 (56.5%) 0.032
cagE/virB11 14 (56%) 20 (29.0%) 0.025
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In contrast to studies of cagE, those related to the gene virB11 are
more frequently in vitro, with rare reports in vivo.6,16 Therefore, the
aimof this studywas to investigate the frequencyof cagE and virB11
genes in H. pylori isolates from patients with gastric cancer and to
analyze the histology proﬁles.
2. Materials and methods
2.1. Clinical specimens
This study was approved by the ethics committee of the Federal
University of Ceara´ and all subjects signed an informed consent
form before inclusion. Samples from 101 patients with gastric
carcinoma who had undergone gastrectomy were collected from
two hospitals in the state of Ceara´, Brazil:Walter Cantı´deo Hospital
at the Federal University of Ceara´ and Saint House of Mercy in
Fortaleza, both located in Fortaleza, the state capital. Histological
classiﬁcation was done according to the Lauren classiﬁcation and
the tumors were staged according to the TNM criteria (tumor,
node, metastasis) by the study team of pathologists.
2.2. DNA extraction
Genomic DNA was extracted from frozen tumor tissue using
cetyltrimethyl ammonium bromide (CTAB), as per the method of
Foster and Twell, with some modiﬁcations.17 DNA extraction was
done only in fragments that presented more than 80% of tumor
cells and the quality was analyzed by 1% agarose gel electropho-
resis with ethidium bromide staining.
2.3. H. pylori and cagE and virB11 gene detection
H. pylori infection was detected by ampliﬁcation of the urease C
(ureC) gene using oligonucleotide primers for PCR, as described by
Lageet al.18Thepresenceof the cagEandvirB11geneswas identiﬁed
in the H. pylori-positive samples using the primers described by
Sozzi et al.6 The PCR mixtures for ampliﬁcation of both genes were
prepared in a volume of 25ml using MasterMix (Taq DNA
polymerase, dNTPs and MgCl2) according to the manufacturer’s
instructions (Promega), adding 0.8% of Tween 20, 0.4mM of each
primer, and 1ml of the DNA sample. PCR productswere analyzed by
1% agarose gel electrophoresis with ethidiumbromide staining. The
sample was considered H. pylori-positive when a ureC fragment of
294 bpwas ampliﬁed,while cagE and virB11 geneswere considered
positive when fragments of 509 bp and 491 bp, respectively, were
detected. We used known DNA to be H. pylori-positive as a positive
control. DNAse-free water was used as a negative control. DNA
preservation was also conﬁrmed by ampliﬁcation of different genes
using other approaches in our laboratory. Random samples were
reanalyzed for conﬁrmation of the results.
2.4. Statistical analysis
Statistical analyses were carried out using Epi Info 6.04d
(Centers for Disease Control and Prevention, Atlanta, GA, USA) and
SPSS 12.0 (SPSS Inc., Chicago, IL, USA) programs. Statistically
signiﬁcant differences were evaluated by the Chi-square test.
Results were considered statistically signiﬁcant when the p-values
were less than 0.05.
3. Results
Among the 101 cases analyzed, 68 (67.3%) were male and 33
(32.7%) female. The average age was 62.7 years, ranging from 23 to
90 years. The most frequent tumor site was the gastric non-cardia(76/101 (75.2%) vs. cardia 25/101 (24.8%)). Intestinal and diffuse
types presented similar frequencies: 58 (57.4%) and 43 (42.6%),
respectively.
3.1. Detection of H. pylori and presence of cagE and virB11 genes
H. pylori infection was detected in 94 of the 101 (93.1%)
gastric carcinomas. H. pylori-positive cases were more frequent-
ly male (64/94 (68.1%)). H. pylori infection was detected more
frequently in non-cardia tumors (73.4% (69/94)) than in cardia
tumors (26.6% (25/94)). Among these H. pylori-infected cases,
the intestinal histology type was slightly more frequent (58.5%
(55/94)). The cagE gene was found in 53.2% (50/94) and the
virB11 gene in 60.6% (57/94) of the cases. Additionally, the cagE
and virB11 genes had a signiﬁcant positive correlation (r = 0.728,
p = 0.000).
3.2. Relationship between H. pylori infection and cagE and virB11
genes with gastric cancer
To investigate the relationship between the H. pylori infection
and the presence of cagE and virB11 genes in gastric cancer, we
divided the cases into four groups according to the presence of
these genes: cagE+/virB11+, cagE+/virB11, cagE/virB11+, and
cagE/virB11. The frequency of cases was 50% (47/94) in cagE+/
virB11+, 3.2% (3/94) in cagE+/virB11, 10.6% (10/94) in cagE/
virB11+, and 36.2% (34/94) in cagE/virB11.
Table 1 shows the distribution of the four groups according to
gastric site. It is noteworthy that the cagE+/virB11+ group was
predominant in non-cardia tumors (56.5%) and the cagE/virB11
group was more frequent in tumors situated in the gastric cardia
(56%).
Fig. 1 shows the distribution of groups according to tumor stage.
The cagE+/virB11+ group was present from stage IB, being the most
frequent at stages IB, II and IV. Although the cagE/virB11 group
was present from stage IA, it was more frequent at stage III. Despite
the small numbers in the cagE+/virB11 and cagE/virB11+ groups,
the former was restricted to the advanced stages (III and IV), while
the latter was represented at almost all stages.
Fig. 2. Distribution of cases by tumor size (T1, T2, T3 and T4) in the four deﬁned
groups: cagE+/virB11, cagE/virB11+, cagE+/virB11 and cagE/virB11.
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involvement and metastases as well as tumor size (TNM), we
analyzed the data for tumor size alone to better verify whether H.
pyloriwas present at the beginning of tumorigenesis (Fig. 2). In this
distribution, it was possible to observe that the cagE+/virB11+
group was the most frequent at tumor sizes T2 and T3.
Fig. 3 shows the distribution of cases by lymph node
involvement. The cagE+/virB11+ group was the most frequent in
N0, N1 and N2 cases. The majority of the H. pylori-infected gastric
cancers did not show metastasis (Fig. 4).Fig. 3. Distribution of cases by lymph node involvement (N0, N1, N2, N3, Nx) in the
four deﬁned groups: cagE+/virB11, cagE/virB11+, cagE+/virB11 and cagE/
virB11.
Fig. 4. Distribution of cases by presence/absence of metastasis (M0, M1, Mx) in the
four deﬁned groups: cagE+/virB11, cagE/virB11+, cagE+/virB11 and cagE/
virB11.4. Discussion
Several studies have reported the inﬂuence of particular
virulence genes (mainly vacA and cagA) on the clinical outcome
of H. pylori infection in different geographical regions. Neverthe-
less, the clinical relevance of these putative virulence-associated
genes of H. pylori is still a matter of controversy. The cytotoxin-
associated gene cagA, which codes for the outer membrane protein
CagA,was initially considered an important virulence factor, due to
its association with some gastrointestinal diseases.19–21 However,
subsequent studies have provided more inconsistent results.22,23
Miehlke et al.22 demonstrated that up to 80% of subjects without
ulcer disease in Texas were infected with H. pylori strains that
possessed cagA. In China and Japan, cagA-positive strains are nearly
universally present and not associated with disease complica-
tions.24,25 In children, infection with cagA-positive strains has not
been consistently associated with peptic ulcer disease.26–28 These
ﬁndings suggest that polymorphism of the cagA gene can be
relevant,3,9 but the presence of other possible H. pylori virulence
genes may also be. The other virulence factor of H. pylori most
studied is vacA, which presents genotype and geographic variation,
with the genotype vacA s1m1 associated with more severe
gastrointestinal diseases.29,30 Even so, the presence of cagA and
vacA has not been sufﬁcient to explain diseases related to H. pylori
infection.
Therefore, the pathogenicity of H. pylori strains could be related
to the presence of other cag-PAI genes. Among these genes, cagE
and virB11 stand out: these genes are located on different sides of
the cag-PAI, so they can also be used as markers of the presence of
this island, as proposed by some authors;1,2,4,6 they also have
pathogenic potential due to their critical functions.1,8 Thus, we
examined the frequency of H. pylori and the relationship between
cagE and virB11 genes and the histological data.
The current study demonstrated the frequency of H. pylori
infection to be 93.1% in gastric cancer cases. This frequency is
similar to that reported in another study from Brazil by Thomazini
et al.,31 which reported a frequency of 95%, and a study from
Turkey by Saribasak et al.,32 which reported a frequency of 100%.
Both of these studies used PCR to detectH. pylori infection in gastric
cancers. In addition, Nomura et al.,33 found 94% prevalence of H.
pylori infection in gastric cancer by serology, in a study conducted
in Hawaii. On the other hand, these frequencies are higher than
those found in the majority of previous studies, which have
reported frequencies between 52% and 69%. However, most of
these have used serology and histology to detect H. pylori
infection.34–36
The cagE gene was found in 53.2% of H. pylori-positive gastric
cancer cases. This is the ﬁrst study to analyze the frequency of cagE
in gastric cancer separately. Table 2 shows the frequency of the
cagE gene found in studies of gastrointestinal diseases.11–13,21,37–39
These studies show that the frequency of the cagE gene is highest in
more severe diseases, such as ulcer and gastric cancer, than in
gastritis, suggesting that this gene may be important in the
progression of these diseases. Likewise, the virB11 gene was found
in a signiﬁcant (60.6%) number of the gastric cancer cases analyzed.
So far, there have been no studies linking the presence of gastric
cancer to virB11. The only two studies found in the literature at the
time of writing were those of Tomasini et al.16 and Sozzi et al.,6
both of which studied dyspeptic Italian patients with duodenal
ulcer, non-atrophic gastritis and atrophic gastritis. These studies
found the virB11 gene to be present in 90% and 94.7% of the cases,
respectively, both higher than the frequency found in the present
study.
The frequency of the cagE gene found in the present study was
lower than in others (Table 2), but this could be due to the small
number of gastric cancer cases analyzed in those studies. Also, the
Table 2
Frequencies of cagE found in the literature
Author, year [Ref.] Frequency (n/N) Population Disease
Lima et al., 2008 [present study] 53.2% (50/94) Brazilian Gastric cancer
Ali et al., 2005 [13] 100% (14/14) India Gastric cancer
Erzin et al., 2006 [37] 81.8% (27/33) Turkey Gastric cancer
Chomvarin et al., 2008 [12] 93.8% (15/16) Thailand Gastric cancer
Day et al., 2000 [11] 92.3% (12/13) Canada Duodenal ulcer
Erzin et al., 2006 [37] 67.9% (19/28) Turkey Duodenal ulcer
Chomvarin et al., 2008 [12] 90% (18/20) Thailand Gastric ulcer
Chomvarin et al., 2008 [12] 85.7% (12/14) Thailand Duodenal ulcer
Audibert et al., 2001 [38] 64.7% (99/153) France Ulcer/gastritis
Lehours et al., 2004 [39] 56.4% (22/39) France Gastritis
Erzin et al., 2006 [37] 26.7% (8/30) Turkey Dyspepsia
Chomvarin et al., 2008 [12] 87.1% (54/62) Thailand Non-ulcer gastritis
Mo´dena et al., 2007 [21] 88.9% (72/81) Brazilian Some gastric duodenal diseases
V.P. Lima et al. / International Journal of Infectious Diseases 14 (2010) e613–e617e616frequency of the virB11 gene was lower than that found in studies
of other gastric diseases. Besides the signiﬁcance of the number of
cases studied, these differences may be related to regional
variations in circulating H. pylori strains, since the bacterium is
known to have great genomic variability.1
Together, these studies point to the importance of these genes
in the progression and severity of gastric diseases. In fact, the
VirB11 protein is strategically located in the type IV secretion
system, associated with ATPase activity, and cagE is considered as
contributing to the construction of the cag type IV secretion system
and inducing the secretion of cytokines, such as interleukin-8, from
infected host epithelial cells.
To verify the inﬂuence of cagE and virB11 genes of H. pylori on
gastric cancer, we divided the cases into four groups based on the
presenceor absence of these genes.Although thegastric antrumwas
the most prevalent site of gastric cancer withH. pylori infection, the
cagE/virB11 group showed a slight increase in incidence of
tumors located in the gastric cardia. Since this region is associated
with the development of tumorswithoutH. pylori infection,40,41 the
strains found in the cardia region may be less virulent.
Reports of the association of H. pylori with histological types of
gastric cancer are controversial and there are no reports
associating histological subtypes and H. pylori genotypes. The
intestinal type was prevalent in the cagE/virB11+, cagE+/virB11+,
and cagE/virB11 groups. However, in spite of the small number
of cases, the cagE+/virB11 group was only found in the diffuse
type. Some studies have shown an association between H. pylori
and the intestinal type,33,42 while others have observed a similar
distribution between the two histological types.42,43 Palestro et
al.,44 reported that H. pylori infection may also be involved in the
pathogenesis of diffuse gastric cancer. These variations could be
due to the presence of strain factors that were not analyzed here,
associated with host genetic predisposition, such as mutation in
the E-cadherin gene.45,46
There are only a few studies reporting the relationship between
gastric cancer and H. pylori infection and tumor stage, such as that
of Luo et al.47 They found a higher frequency of H. pylori infection
at stage II. In the present study, we found the presence of H. pylori
beginning at the early stages with cagE+/virB11+ and cagE/
virB11. The presence of H. pylori cagE+/virB11+ from the earlier
stages and the high frequency at all stages suggest that this strain
can bemore pathogenic than others and also that this strain can be
important in gastric tumorigenesis. This aspect was conﬁrmed by
the presence of theH. pylori cagE+/virB11+ in tumors of a small size.
Studies reporting high frequencies of these genes in more
aggressive gastric diseases support this idea.6,11–13,16 On the other
hand, the presence of the cagE/virB11 group could be due to
other virulence factors of H. pylori or even associated with other
risk factors, such as particular foods, alcohol and smoking, which
were not studied.Finally, this study is the ﬁrst to include a relevant number of
gastric cancer cases with H. pylori infection, reporting the
frequency and relationship of cagE and virB11 genes and also to
analyze the presence of these genes focusing on histological
aspects. The results presented here indicate that these genes,
which are part of the cag-PAI, are important virulence factors of H.
pylori in bacterial pathogenesis.
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